| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $71.4M | -1.2% |
| SG&A Expense | $101.0M | +61.0% |
| Operating Income | -$172.4M | -27.7% |
| Interest Expense | $27.3M | +302.3% |
| Income Tax | $0 | — |
| Net Income | -$197.7M | -37.4% |
| EPS (Basic) | -$5.05 | -29.8% |
| EPS (Diluted) | -$5.05 | -29.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.4M | -15.2% |
| Current Assets | $160.5M | -13.9% |
| Total Assets | $164.8M | -13.0% |
| Current Liabilities | $26.2M | +38.7% |
| Long-term Debt | $95.3M | +6.2% |
| Total Liabilities | $239.6M | +104.3% |
| Stockholders' Equity | -$74.8M | -203.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$146.5M | +1.4% |
| Capital Expenditures | $1.0M | +217.4% |
| Investing Cash Flow | -$1.0M | -217.4% |
| Financing Cash Flow | $120.0M | +168.5% |
| Free Cash Flow | -$147.6M | +0.9% |